THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
A part of Timm Medical’s product offering is Petros’ patent-protected oral phosphodiesterase 5 (PDE5) inhibitor for the treatment of ED. Via these innovative products, Timm Medical has helped thousands of men with erectile dysfunction, prostate cancer, and penile rehabilitation address their erectile health with an at-home therapeutic regimen and under the guidance of their practitioner.![]()
For several years, being a small privately held company, we could not execute our vision, and Petros gave us that edge
Share this Article:
Tweet
|
Company
Timm Medical Technologies
Headquarters
Fort Washington, PA
Management
Andy Gesek, President
Description
Petros Pharmaceuticals, a leading provider of therapeutics for men’s health, strategically acquired Timm Medical Technologies, a manufacturer and distributor of medical-grade devices for the treatment of erectile rehabilitation and sexual dysfunction, with the intent to develop first-in-class device technology within the men’s health marketplace. Today, Petros’ wholly-owned unit, Timm Medical, is dedicated to consistently combining quality products with the best-in-industry service levels to exceed its customers’ expectations. The firm is looking at new ways to bring men’s health solutions to all the stakeholders involved to drive value and reimagine how care is delivered for men’s health problems in the future. Via these innovative products, Timm Medical has helped thousands of men with erectile dysfunction, prostate cancer, and penile rehabilitation address their erectile health with an at-home therapeutic regimen and under the guidance of their practitioner
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info